CD44 and breast neoplasm: Although not typical of all the important studies, Kim et al., in a retrospective study involving tissue microarray blocks of 643 cases of invasive breast carcinomas, have found that the CD44+/CD24- marker was taken as a positive prognostic subgroup in breast neoplasm [32], as explained in Table 2.